For research and educational purposes only. Not intended for human consumption.
Glow Protocol
Limited Research- •Multi-peptide skin rejuvenation combination
- •BPC-157 + TB-500 + GHK-Cu synergy data
- •Collagen and angiogenesis pathway research
Multi-Peptide Skin Rejuvenation Complex | BPC-157 + TB-500 + GHK-Cu
Overview
What is Glow Protocol?
The Glow Protocol is a peptide combination featuring BPC-157, TB-500, and GHK-Cu (Copper Peptide) marketed for skin rejuvenation and anti-aging. While individual components have research backing, combination protocols require careful dosing consideration. BPC-157 provides anti-inflammatory effects, TB-500 supports angiogenesis, and GHK-Cu stimulates collagen production.
Key Benefits
Combination delivery of three regenerative peptides in single injection for comprehensive skin and tissue support. Targets multiple aging pathways: collagen loss, tissue repair, and cellular regeneration.
Mechanism of Action
BPC-157 provides anti-inflammatory effects and tissue repair, TB-500 supports angiogenesis and cell migration, and GHK-Cu stimulates collagen and elastin production through gene modulation. Fixed-ratio combinations may deliver individual peptides at varying therapeutic intensities.
Molecular Information
Pharmacokinetics
Research Indications
Skin Rejuvenation
GHK-Cu stimulates collagen and elastin production. Combined with tissue repair peptides for comprehensive skin support.
Collagen Synthesis
GHK-Cu has demonstrated ability to increase collagen production in multiple studies. Supports skin firmness and elasticity.
Anti-Aging Support
Combination targets multiple aging pathways: collagen loss, tissue repair, and cellular regeneration.
Research Protocols
Disclaimer: CRITICAL: Calculate individual peptide doses before starting any protocol. Standard combination ratios may exceed therapeutic ranges for some peptides. Consider individual peptides if precise dosing control is needed.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Conservative Approach | Calculate individual peptide amounts | Based on component requirements | Subcutaneous |
| Standard Protocol | Per supplier guidelines | As recommended | Subcutaneous |
| Individual Peptide Alternative | Separate peptides | Optimized schedules | Multiple injections |
Timing: Consider individual peptide half-lives and optimal dosing schedules for each component. Consistent timing preferred.
Peptide Interactions
How to Reconstitute
Important: Always use bacteriostatic water (BAC). Sterile technique is essential.
Verify vial contents and individual peptide amounts
Calculate target concentration based on individual peptide therapeutic doses
Allow to reach room temperature
Clean vial tops with alcohol swabs
Add calculated volume of bacteriostatic water
Gently swirl until completely dissolved (do not shake)
Label with reconstitution date and peptide concentrations
Store refrigerated at 2-8°C, use within 28 days
Dosing Calculator
Calculate your injection volume with visual dosing guide
To obtain 250 mcg from this solution:
Draw 0.10 mL=10 units
(1 mL = 100 units on any insulin syringe)
Draw to this mark for 250 mcg
This calculator is for research purposes only. Always verify calculations and consult protocols.
Quality Indicators
Blue Solution
Solution should have a light blue hue from GHK-Cu copper content, clear without particles.
Proper Packaging
Vial should clearly state individual peptide amounts, not just total weight.
Copper Discoloration
Temporary blue-green discoloration at injection sites is normal with GHK-Cu.
Excessive Individual Peptide Amounts
Do not use if individual peptide doses exceed recommended therapeutic ranges.
What to Expect
- •Individual responses vary significantly based on peptide ratios
- •Effects primarily from individual component peptides
- •May require dosing adjustments based on individual peptide tolerance
- •Monitor for effects and side effects of each component peptide
- •Community polls: 75% report positive results, 70% would recommend
Side Effects & Safety
Side Effects
- •Calculate individual peptide doses before starting
- •Monitor for copper accumulation effects (temporary skin discoloration)
- •Consult healthcare provider familiar with peptide dosing
- •Start with minimal doses to assess tolerance
- •No safety studies on three-peptide combination
When to Stop
- •Adverse effects
- •Excessive skin discoloration
- •Unusual symptoms
- •As directed by provider
References
3 StudiesBPC-157 Tissue Repair Mechanisms (2024)
Laboratory Study | Individual Peptide | Multiple Studies | Dose range 250-500mcg daily
Research on BPC-157 individually shows wound healing and anti-inflammatory properties at specific therapeutic doses.
TB-500 Angiogenesis Studies (2024)
Preclinical Research | Individual Peptide | Animal Models | 2-5mg twice weekly
TB-500 research shows tissue regeneration effects when dosed 2-5mg twice weekly.
Combination Peptide Protocols: Limited Data (2024)
Review Study | Combination Therapy | Clinical Observation | Variable dosing
Limited formal research exists on fixed-ratio peptide combinations, with most protocols based on clinical experience rather than controlled studies.
Quick Start Guide
Research Disclaimer
Glow Protocol is sold for laboratory research purposes only and is not intended for human or animal consumption. The information provided on this page is compiled from published research, veterinary studies, and anecdotal reports for educational purposes. This content does not constitute medical advice, diagnosis, or treatment recommendations. Any research involving Glow Protocol must comply with all applicable local, state, and federal regulations. BioInfinity Lab makes no claims regarding the safety or efficacy of Glow Protocol for any purpose. Consult qualified professionals for any research applications.